United States Pharmacopeia

VAV Enters LatAM with High-Purity Lipids, Eyes 40% Share in Five Years

Retrieved on: 
Thursday, March 7, 2024
Cosmetics, Retail, Health, Research, Science, Pharmaceutical, Biotechnology, ISO, COSMOS, USD, Food safety, Marketing, United States Pharmacopeia, Lecithin, Occupational safety and health, OSHA, Vaccine, API, Anesthesia, VAV, Phospholipid, Liposome, USP, All, Kedia

VAV Lipids is headquartered in Mumbai, India and is among the world’s leading manufacturers of phospholipids and lecithins.

Key Points: 
  • VAV Lipids is headquartered in Mumbai, India and is among the world’s leading manufacturers of phospholipids and lecithins.
  • The biopharmaceutical company manufactures plant phospholipids (LECIVA), egg phospholipids (LIPOVA), synthetic phospholipids and neutral lipids, APIs and specialty proteins.
  • VAV Lipids will introduce its entire range of products through the company’s distribution network in Latin America.
  • Arun Kedia, Managing Director of VAV Lipids, said, “Our expansion into Latin America will boost our global presence significantly.

Vitaquest International Secures USP Verification at All Manufacturing Sites

Retrieved on: 
Monday, January 22, 2024
Certification, Health, USP, NSF, GMP, FSSC 22000, United States Pharmacopeia, Quality control, FSSC, Dietary supplement, NextGen Healthcare, Halal, QCM, Health Canada, Orthodox Union, Quality Assurance International

Custom Manufacturer of Health & Wellness Consumer Products Takes Next Step in Drive to Lead Quality and Trust

Key Points: 
  • Vitaquest produces over 4,000 health and wellness consumer products at three different facilities, and all these facilities have now successfully completed the USP program.
  • To secure USP Verification, Vitaquest successfully completed a multi-step process that included GMP facility audits, and product quality control and manufacturing (QCM) process evaluation.
  • United States Pharmacopoeia (USP) Quality Systems GMP Audit Program is one of many dietary supplement programs the organization has successfully completed.
  • Vitaquest has successfully completed the United States Pharmacopoeia (USP) Quality Systems GMP Audit Program for three of its facilities, following an extensive review of its dietary supplement manufacturing systems and processes.

Global Filtration Market (Focus on Biologics Manufacturing) Report 2023: Featuring Asahi Kasei, Cobetter Filtration, Corning, Merck, Pall, Parker Hannifin, Sartorius, Thermo Fisher & More - ResearchAndMarkets.com

Retrieved on: 
Wednesday, April 5, 2023
Biotechnology, Pharmaceutical, Health, Vaccine, United States Pharmacopeia, China Biologic Products, GMP, Good, Maintenance, Prevalence, Clogging, CPC, Overalls, Parker Hannifin, Ultrafiltration, Research, Thermo Fisher Scientific, USP, Element, Antibody, Type, Government, Sterilization, Organization, Protein, Patent, Investment, Nature, Good manufacturing practice, Risk, Conditional sentence, Growth, Merck, Filtration, Bacteria, Geography, Virus, Sartorius, Green bridge (filtration system), Safety, Sewage treatment, Fine chemical, Marketing, Filter

A key advancement in this industry has been the introduction of novel filtration systems, such as depth filtration systems, tangential flow filtration systems, virus filtration systems and chromatography filtration systems.

Key Points: 
  • A key advancement in this industry has been the introduction of novel filtration systems, such as depth filtration systems, tangential flow filtration systems, virus filtration systems and chromatography filtration systems.
  • Driven by these benefits, the demand for efficient biopharmaceutical filtration systems is anticipated to increase, resulting in lucrative opportunities for developers.
  • It also presents information on the factors affecting sterile filtration, advantages of biopharmaceutical filtration systems, challenges associated with biopharmaceutical filtration systems and applications of biopharmaceutical filtration.
  • Answer: The various types of filtration systems used in biomanufacturing processes include depth filtration systems, tangential flow filtration systems, virus filtration systems, other membrane filtration systems and chromatography filtration systems.

Top Selling Direct-to-Consumer Prenatal Multivitamin Brand Ritual Launches Nationwide in Target

Retrieved on: 
Tuesday, April 4, 2023
Baby, Maternity, Other Retail, Other Consumer, Other Health, Health, General Health, Women, Vitamins, Supplements, Men, Retail, Consumer, The Non-GMO Project, Science, United States Pharmacopeia, Target Zero, Woman, Essential, Target Corporation, Dietary supplement, Target

Ritual , the traceable health and wellness brand working to raise the standard in the supplement industry, today announced the launch of its daily multivitamins and leading prenatal multivitamin nationwide at Target and on Target.com.

Key Points: 
  • Ritual , the traceable health and wellness brand working to raise the standard in the supplement industry, today announced the launch of its daily multivitamins and leading prenatal multivitamin nationwide at Target and on Target.com.
  • “We’re excited to bring our commitment to traceability to Target shelves across the country and empower guests to make confident choices for their health,” said Katerina Schneider, Founder and CEO of Ritual.
  • Target will carry Ritual’s high-quality daily multivitamins for adult men and women ( Essential for Men 18+ and Essential for Women 18+ ) and its leading prenatal multivitamin ( Essential Prenatal ) in all Target stores and on Target.com.
  • Ritual’s flagship daily multivitamin, Essential for Women 18+, is part of Target Clean .

In-line UV-vis Spectroscopy Market Size, Share & Trends Analysis Report 2022: Pharmaceutical/Chemical - Global Forecast to 2030 - ResearchAndMarkets.com

Retrieved on: 
Friday, January 20, 2023
Pharmaceutical, Hardware, Technology, Food, Beverage, Retail, Science, Chemicals, Plastics, Other Technology, Food Tech, Manufacturing, Other Science, Health, Internal, Pharmaceutical industry, Nuclear magnetic resonance, Laboratory, Protein, Therapy, Certified reference materials, Chemical industry, Workflow, Environmental monitoring, NBE, USP, National Institute of Standards and Technology, Indium gallium arsenide, European Pharmacopoeia, Certification, Spectrophotometry, Research, United States Pharmacopeia, Calibration, LED, Dicarboxylic acid, USD, Quality control, Pharmacy, Non-Euclidean geometry, Agriculture, IR, COVID-19, NMR, Silicon, Ultraviolet–visible spectroscopy, Sewage treatment, Speciality chemicals, Medical device, Video game

The "In-line UV-vis Spectroscopy Market Size, Share & Trends Analysis Report by Application (Color Measurement, Chemical Concentration), by End-user (Pharmaceutical Industry, Chemical Industry), and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "In-line UV-vis Spectroscopy Market Size, Share & Trends Analysis Report by Application (Color Measurement, Chemical Concentration), by End-user (Pharmaceutical Industry, Chemical Industry), and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.
  • UV/Visible spectrophotometers are widely used by laboratories, including that associated with academia and governments, as well as other industries.
  • Thus, accurate calibration of the wavelength axis is important for applications that rely on spectroscopic techniques for compound testing, to receive regulatory approval.
  • These factors have driven the use of other spectroscopy methods, thereby limiting the revenue growth in this industry.

Inteleos Appoints Two New Members to Board of Directors

Retrieved on: 
Friday, January 27, 2023
MD, UC, Artificial intelligence, Non-governmental organization, Neil, Chair, Master of Business Administration, Policy, Johns Hopkins Bloomberg School of Public Health, Intelligence, Machine learning, Knowledge, United States Pharmacopeia, Global health, Public health, RPVI, International health, Business administration, AI, University of California, Irvine, Patient, Problem solving, Sahota, Maternal health, RVT, Nursing, Management

ROCKVILLE, Md., Jan. 27, 2023 /PRNewswire/ -- Inteleos, a non-profit global healthcare certification organization, today announced the appointment of Vera M. Zlidar and Neil Sahota to its board of directors effective January 1. Zlidar serves the board with expertise in global health focusing on maternal fetal healthcare. Sahota supports the board with his expertise in machine learning and artificial intelligence. Both will help expand the organization's mission to improve global health through assessments while enhancing patient safety.

Key Points: 
  • ROCKVILLE, Md., Jan. 27, 2023 /PRNewswire/ -- Inteleos, a non-profit global healthcare certification organization, today announced the appointment of Vera M. Zlidar and Neil Sahota to its board of directors effective January 1.
  • Zlidar serves the board with expertise in global health focusing on maternal fetal healthcare.
  • "We are incredibly proud to welcome such uniquely qualified individuals to our board," said Michael Lilly, MD, RPVI, RVT, Chair, Inteleos Board of Directors.
  • "I am deeply honored to be selected to the Board, and I am excited to contribute to the mission of Inteleos."

ProSomnus® Announces Medicare Reimbursement for ProSomnus EVO® [PH] Sleep Apnea and Snoring Device

Retrieved on: 
Thursday, December 15, 2022
IRB, Choking, Heart failure, PDAC, Anatomy, Patient, Intellectual property, Register, Entrepreneurship, SAN, Failure, Dentist, Security (finance), Hypertension, Continuous positive airway pressure, Food, Marketing, Obstructive sleep apnea, FDA, EVO, Sleep, Somnolence, Regulation of tobacco by the U.S. Food and Drug Administration, Stroke, Healthcare Common Procedure Coding System, Press release, United States Pharmacopeia, Form 10-K, CPAP, Medicare, HCPCS, OAT, Lakeshore, Data analysis, Risk, COVID-19, Form, Pharmaceutical industry, Medical device, Coding

The Pricing, Data Analysis, and Coding (PDAC) Contractor has reviewed and verified the device for the Healthcare Common Procedure Coding System (HCPCS) code E0486.

Key Points: 
  • The Pricing, Data Analysis, and Coding (PDAC) Contractor has reviewed and verified the device for the Healthcare Common Procedure Coding System (HCPCS) code E0486.
  • Per Medicare coding guidelines, the ProSomnus EVO [PH] device repositions and stabilizes the patient’s jaw during sleep, increasing pharyngeal space and reducing the risk of upper airway collapse.
  • The device is approximately 32% smaller than predicate devices and features unique comfort bumps around key components.
  • The device has unique advancement markings and visual indicators to make it easier for beneficiaries to use the device and to communicate with their healthcare providers throughout treatment.

ProSomnus® Announces FDA 510(k) Clearance for ProSomnus EVO™ [PH] Sleep and Snore Device

Retrieved on: 
Wednesday, November 2, 2022
Marketing, MD, EVO, Sub, CPAP, SEC, GLOBE, Industry, COVID-19, Securities Exchange Act of 1934, United States Pharmacopeia, Virgin Islands, Form 10-K, Adoption, OAT, Company, FDA, Somnolence, Dentist, Failure, Obstructive sleep apnea, Anatomy, LLC, Nasdaq, Press release, Regulation of tobacco by the U.S. Food and Drug Administration, Choking, U.S. Securities and Exchange Commission, Patient, Prevalence, Drug Quality and Security Act, Continuous positive airway pressure, Security (finance), Entrepreneurship, 100,000, Acquisition, Sleep, Precision, Hypertension, Risk, Stroke, British Virgin Islands, Sung Kim, Xi, SAN, Heart failure, Intellectual property, Securities Act of 1933, Register, Form, XV, Medicare, HGP, Food, Forward-looking statement, Medical device, Pharmaceutical industry, Group purchasing organization

SAN FRANCISCO, Nov. 02, 2022 (GLOBE NEWSWIRE) -- ProSomnus (“the Company”), a pioneer in precision medical devices for the treatment of Obstructive Sleep Apnea (OSA), today announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for the ProSomnus EVO™ [PH] Sleep and Snore Device. The device joins the Company’s flagship product, the ProSomnus EVO™, in its line of FDA-cleared, patient-preferred, less invasive Precision Oral Appliance Therapy (OAT) devices for the treatment of OSA.

Key Points: 
  • The ProSomnus EVO [PH] Sleep and Snore Device is specifically engineered to meet Centers for Medicare Services coding guidelines, offering Medicare beneficiaries a non-invasive, comfortable, easy-to-use, and effective alternative to CPAP machines, surgical procedures, and legacy oral devices.
  • Every ProSomnus EVO [PH] device is personalized and digitally manufactured based upon the patients unique anatomy and healthcare providers treatment plan for each patient.
  • The ProSomnus EVO [PH] is the only Herbst-style device made from engineered, Medical Grade Class VI-rated material, the highest material quality grade offered by US Pharmacopeia.
  • Receiving FDA clearance for the ProSomnus EVO [PH] is a significant milestone for the Company and for patients suffering from OSA, said Len Liptak, Co-Founder and Chief Executive Officer of ProSomnus.

Inspire Agency CEO Joins SCBIO Board of Directors

Retrieved on: 
Tuesday, November 1, 2022
Marketing, Awareness, Maryland School, CEO, BIO, Agency, School, Catalent, Arizona State University Research Park, Inspiration, Organization, History of the University of Maryland, College Park, Johns Hopkins, Mental health, United States Pharmacopeia, Health, Human, University, Social media, Medicine, University of Maryland School of Medicine, Association, USP, VC, Environment, Quality of life, Johns Hopkins Berman Institute of Bioethics, Medtech, Management, Public relations, Bogus

MOUNT PLEASANT, S.C., Nov. 1, 2022 /PRNewswire/ -- Inspire Agency announced today that its President and CEO, Juliette Bogus, has joined the SCBIO Board of Directors, bringing her two-plus decades of healthcare, life sciences and medtech experience to South Carolina's non-profit life sciences and economic development organization.

Key Points: 
  • "We're excited to welcome Juliette to the SCBIO Board," said SCBIO President and CEO James Chappell.
  • Before starting her own agency, Bogus held positions at several full-service national agencies in both D.C. and Baltimore.
  • In 2013, Bogus founded Inspire Agency, a full-service branding and content agency that provides brand development, content marketing, media relations and corporate communications.
  • Inspire Agency (Inspire) is a branding and content marketing agency helping brands find their voice.

Aldeyra Therapeutics Schedules Conference Call and Webcast to Announce Top-Line Results from Part 1 of the Phase 3 GUARD Trial of ADX-2191 in Proliferative Vitreoretinopathy

Retrieved on: 
Wednesday, October 5, 2022
Health, Clinical Trials, Research, Pharmaceutical, Science, Biotechnology, LinkedIn, Therapy, Webcast, Part, Patient, Twitter, Inflammation, Nasdaq, Toxicity, RASP, Duane syndrome, Allergic conjunctivitis, United States Pharmacopeia, PVR, Retinitis pigmentosa, Broadcasting, Vaccine, Facebook

The dial-in numbers are (844) 200-6205 for domestic callers and (646) 904-5544 for international callers.

Key Points: 
  • The dial-in numbers are (844) 200-6205 for domestic callers and (646) 904-5544 for international callers.
  • A live audio webcast of the conference call also will be accessible from the Investors & Media section of Aldeyra's website at ir.aldeyra.com .
  • After the live webcast, the event will remain archived on Aldeyras website for 90 days.
  • ADX-629, an orally administered RASP modulator, is in Phase 2 clinical testing for the treatment of systemic immune-mediated diseases.